NCT07567040: Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial

Study type: INTERVENTIONAL. Phase: PHASE3.

Publisher

ClinicalTrials.gov

USA

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher: ClinicalTrials.gov
Region: USA
Scope: Research
Published: July 13, 2026
Language: EN

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Summary excerpt

Study type: INTERVENTIONAL. Phase: PHASE3.

Source route

Continue on clinicaltrials.gov

Leave the platform to read the original full article on the publisher site.

Source: ClinicalTrials.gov

Scope: Research

Open original article

Related coverage

More related coverage

Universitätsklinikum Erlangen/3h ago

Molecular map of liver disease could transform how MASLD is diagnosed and monitored

NCT07567040: Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial | Pharma Surge

NCT07567040: Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial

More related coverage

Die Kunst des „Im Wandel-Seins“

Catching the Drift: How Wildfire Smoke Plumes May Increase Cancer Risk

Swimmer Archie Goodburn goes from graduation to the Games

Molecular map of liver disease could transform how MASLD is diagnosed and monitored